EBElmostafa Benaissa

Elmostafa Benaissa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elmostafa Benaissa has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human Cellulosimicrobium Infections: A Clinically Oriented Review of Diagnostic and Therapeutic Challenges

    by Elmostafa Benaissa, Najwa Hnach, Yassine Ben Lahlou, Mariama Chadli

    Cellulosimicrobium species, formerly classified within the genus Oerskovia, are environmental Gram-positive filamentous bacilli that rarely cause human infection. Their clinical significance may be underestimated because coryneform Gram-positive rods are frequently interpreted as contaminants in routine cultures. Publications on human infections are dominated by case reports and small case series, most often involving bloodstream infection, infective endocarditis, osteoarticular infection, peritoneal dialysis-associated peritonitis, and endophthalmitis. Reported cases commonly occur in patients with immunosuppression, malignancy, renal replacement therapy, prosthetic cardiac valves, central venous catheters, or other foreign material. Cellulosimicrobium cellulans and its former name Oerskovia xanthineolytica account for most described infections. Diagnostic confirmation usually requires careful interpretation of repeated positive cultures, isolation from sterile sites, and reliable identification using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry or 16S ribosomal ribonucleic acid gene sequencing when available. Therapeutic evidence remains limited, but vancomycin and trimethoprim-sulfamethoxazole generally retain in vitro activity, whereas resistance to beta-lactams and clindamycin has been reported. Management should combine species-level identification, susceptibility testing, appropriate antimicrobial therapy, and source control, including removal of infected devices whenever feasible.

  • Harnessing Artificial Intelligence to Tackle Biofilm Infections: Advances, Challenges, and Perspectives

    by Oussama Grari, Said Ezrari, Imane El Yandouzi, Elmostapha Benaissa, Yassine Ben Lahlou, Mohammed Lahmer, Abderrazak Saddari, Mostafa Elouennass, Adil Maleb

  • Bacteriological profile of biliary tract infections in adults undergoing interventional biliopancreatic endoscopy

    by Abderrazak Saddari, Mohammed Lahmer, Said Ezrari, Yassine Ben Lahlou, Elmostapha Benaissa, Mostafa Elouennass, Adil Maleb


  • Evolutionary trends in antibiotic resistance of Pseudomonas aeruginosa and Acinetobacter baumannii before and during the COVID-19 pandemic

    by Elmostafa Benaissa, Elmehdi Belouad, Benlahlou Yassine, Adil Maleb, Mariama Chadli, Mostafa Elouennass

    Background: Acinetobacter baumannii and Pseudomonas aeruginosa are major causes of healthcare-associated infections and are frequently associated with multidrug resistance. This study aimed to analyze the evolution of antibiotic resistance in Acinetobacter baumannii and Pseudomonas aeruginosa at a Moroccan hospital between 2017 and 2023, with particular focus on the potential impact of the COVID-19 pandemic. Methods: We conducted a retrospective study from January 2017 to December 2023 at the Bacteriology Department of Mohammed V Military Teaching Hospital, Rabat, Morocco. Non-redundant isolates of A. baumannii and P. aeruginosa were identified using conventional methods. Antimicrobial susceptibility was determined by disk diffusion according to CASFM/EUCAST guidelines. Colistin susceptibility was assessed using broth microdilution. Pre-pandemic (2017–2019) and pandemic (2020–2023) resistance rates were compared. Results: A total of 5054 non-redundant isolates were recovered from 4803 patients, including 2840 (56%) P. aeruginosa and 2214 (44%) A. baumannii. During the pandemic, A. baumannii isolates showed significant increases in resistance to amikacin (86% vs. 68%), ceftazidime (95% vs. 87%), ciprofloxacin (93% vs. 89%), imipenem (92% vs. 83%), piperacillin-tazobactam (93% vs. 88%), and tobramycin (74% vs. 58%) (all p < 0.05). Similarly, P. aeruginosa isolates exhibited increased resistance to amikacin (24% vs. 18%), ceftazidime (45% vs. 19%), ciprofloxacin (51% vs. 24%), imipenem (44% vs. 21%), piperacillin-tazobactam (42% vs. 15%), and tobramycin (25% vs. 17%) (all p < 0.05). Colistin resistance remained absent (0%) in both species. Conclusion: Resistance rates in A. baumannii and P. aeruginosa significantly increased during the COVID-19 pandemic, reducing therapeutic options.

  • Bacterial and fungal secondary infections in patients with severe SARS-CoV-2 pneumonitis: Prevalence, epidemiology and resistance profile

    by Elmostafa Benaissa, Mehdi Legdani, Yassine Benlahlou, Adil Maleb, Mariama Chadli, Mostafa Elouennass

    Background: Coronavirus disease (COVID19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus present with mild to severe respiratory illness requiring care in an intensive care unit. However, critically ill patients are likely to develop secondary bacterial infections such as secondary pneumonia, bloodstream infection of unknown origin and catheter-related sepsis. The aim of this study was to investigate the prevalence and potential risk factors for secondary infections, and to identify the incriminating pathogens and their resistance profiles in critically ill patients infected with SARS-CoV-2. Methods. We conducted a single-center retrospective observational study over a 15-month period at the Mohammed V Military Hospital. Clinical specimens were identified using standard microbiological methods. Antimicrobial susceptibility testing was performed using a range of antibiotics recommended by CA-SFM/EUCAST 2021. Results. We collected 138 patients who met our inclusion criteria, 102 of whom developed a secondary infection, i.e. a prevalence of 74%. The most frequent secondary infection was pneumonia (56%), followed by bacteremia (31%) and catheter-related infection (13%). Age, length of stay in intensive care, corticosteroid treatment, diabetes, chronic lung disease and smoking were statistically associated with the acquisition of secondary infections. Secondary fungal infection represented 10%. Secondary infection was dominated by Gram-negative bacilli. Conclusion. In our study, the prevalence of microbial secondary infection was very high. Gram-negative bacilli were the most common germs, with alarmingly high rates of resistance, complicating the therapeutic management of these patients.

  • Open Access

    A hydrocele revealing epididymal tuberculosis

    by Yassine Ben Lahlou, Zakaria Laanibi, Zakaria Malihy, Elmostapha Benaissa, Adil Maleb, Abderrahim Elktaibi, Mariama Chadli, Mostafa Elouennass

    Genitourinary tuberculosis is a severe form of extrapulmonary tuberculosis. The kidneys are the most commonly affected organs, followed by the epididymis, testicles, bladder, ureter and prostate. Notably, epididymal tuberculosis is one of the forms of genital tuberculosis presenting with specific clinical features, which may include epididymitis, orchid-epididymitis or hydrocele. We report the case of a patient with a hydrocele that revealed epididymal tuberculosis. Utilizing molecular biology techniques, a diagnostic test for epididymal tuberculosis was established. The patient was treated conservatively with tuberculosis medication for 6 months.

  • Open Access

    Genotypic study of isolated resistance to isoniazid in the Mycobacterium tuberculosis complex in a Moroccan hospital

    by Amine Amri, Elmostafa Benaissa, Yassine Benlahlou, Fatna Bsaibis, Adil Maleb, Mariama Chadli, Mostafa Elouenass

    Introduction. Despite the introduction 40 years ago of effective and low-cost treatment for tuberculosis (TB), morbidity and mortality from this disease remain substantial worldwide. According to the WHO, TB is once again the leading cause of death worldwide from a single infectious agent. In 2023, TB caused ~1.25 million deaths, surpassing COVID-19. In Morocco, the number of new TB cases rose from 30,897 in 2017 to 35,000 in 2019, highlighting a concerning upward trend that underscores the persistent challenge TB poses to the country’s public health system. The incidence of multidrug-resistant (MDR) or rifampicin (RIF)-resistant TB was estimated at 1.7 per 100,000 inhabitants. Isoniazid (INH) is a cornerstone of first-line TB treatment, and resistance to it, even in the absence of RIF resistance, is associated with delayed treatment response, higher rates of treatment failure or relapse and increased risk of progression to MDR-TB if not promptly identified and appropriately managed. Moreover, current diagnostic algorithms in many settings, including Morocco, may miss INH monoresistance due to their reliance on rapid molecular tests that primarily detect RIF resistance, further emphasizing the emerging threat of drug-resistant TB. Despite this, national data on INH monoresistance remain scarce. Given the increasing burden of TB and the critical importance of early detection of drug resistance, it is essential to better understand patterns of resistance beyond RIF. It is within this context that we conducted the present study, which aims to investigate INH resistance in TB cases (pulmonary or extrapulmonary, new or previously treated) over a period of 3 years. Materials and methods. This is a retrospective study conducted at the Bacteriology Department of Mohammed V Military Instruction Hospital over a period of 3 years. Data were collected via the laboratory information system. Clinical samples underwent treatment using both conventional bacteriological methods and molecular techniques. The study of resistance to major anti-TB drugs was performed using the reverse hybridization technique, specifically the HAIN method (GenoType® MTBDR plus by Hain Lifescience). Statistical analysis was performed using IBM SPSS Statistics 19 and Microsoft Excel 2019. Results. The study involved 464 patients treated for pulmonary and extrapulmonary TB, including both new cases and those previously treated with positive cultures. The mean age of the patients was 42.2 years, with a range from 8 to 88 years. There was a predominance of males at 74%, with a sex ratio of 2.8. Pulmonary sputum samples accounted for 84.8% of the cases, whereas extrapulmonary samples represented only 15.2%, and the positivity rates for direct examination and culture across all samples were 74% and 100%, respectively. INH resistance had a prevalence of 9% (43 out of 464). Genetic mutations observed indicated that 63% of the clinical isolates resistant to INH had mutations in the katG gene, while 37% had mutations in the inhA gene. Conclusion. The increasing prevalence of Mycobacterium tuberculosis complex strains resistant to one or more first-line anti-TB drugs highlights the urgent need for targeted and ongoing epidemiological surveillance. In this study, we found that INH resistance affected 9% of TB cases over the 3-year period, underscoring a significant yet under-recognized threat to TB control efforts in Morocco. Molecular analysis revealed that the majority of resistant strains carried mutations in the katG gene, with a smaller proportion exhibiting mutations in the inhA promoter region. These findings emphasize the importance of incorporating molecular diagnostics capable of detecting INH resistance even in the absence of RIF resistance into routine TB surveillance programmes. Strengthening diagnostic capacity and updating treatment protocols accordingly will be essential to curb the spread of INH-resistant TB and prevent the emergence of MDR forms.


  • Open Access

    Tibial osteitis caused by Mycobacterium tuberculosis

    by Marwa Benjelloun, Naji Tijani, Yassine BenLahlou, Elmostafa Benaissa, Mariama Chadli

    Tuberculosis is a major scourge, posing a serious public health problem in countries where it is endemic. Osteoarticular involvement accounts for 3–5% of all tuberculosis cases and 10–15% of extrapulmonary tuberculosis cases. We report a case of tibial osteitis caused by Mycobacterium tuberculosis in a 52-year-old female patient who presented to the trauma department at the Mohammed V Military Teaching Hospital with a painful swelling of the lower part of her left leg. Standard X-rays and computed tomography scans revealed bone involvement, specifically in the tibia. Additional investigations revealed pulmonary consolidation and splenic nodules. Microscopy (Ziehl–Neelsen staining), GeneXpert MTB/RIF and histopathological examination all returned positive results for M. tuberculosis. In an endemic context, any persistent and atypical bone lesion should raise suspicion of osteoarticular tuberculosis to enable rapid diagnosis and appropriate therapeutic management. In the absence of malignant tumours and other differential diagnoses, the diagnosis of skeletal tuberculosis must be considered, even in the absence of specific clinical signs.


  • Open Access

    Bilateral tuberculous psoas abscesses in an immunocompetent patient: a case report and review of the literature

    by Hamid Laatiris, Hajar Zouaki, Yassine Benlahlou, Benaissa Elmostapha, Mariama Chadli

    Psoas abscess is a rare infection historically associated with tuberculosis (TB), although non-tuberculous bacterial causes, particularly Staphylococcus aureus, have become increasingly common. This type of abscess can be either primary or secondary, and its diagnosis remains challenging due to the non-specific nature of clinical signs. Imaging and microbiological analyses are essential for establishing the diagnosis. We report the case of a 22-year-old patient with no significant medical history, who presented with persistent mechanical low back pain for 18 months. Initial computed tomography revealed a non-compressive disc protrusion, leading to treatment with non-steroidal anti-inflammatory drugs, without improvement. Further investigations revealed an extrapulmonary spinal localization of TB in an immunocompetent patient, with bilateral psoas abscesses caused by Mycobacterium tuberculosis, confirmed by the Ziehl–Neelsen staining, auramine staining, culture on Löwenstein–Jensen medium and GeneXpert PCR. Anti-TB treatment was initiated, resulting in favourable clinical evolution.


  • Open Access

    Unusual association of primary parotid and conjunctival tuberculosis in a young immunocompetent patient: a case report

    by Mariam Hachimi Idrissi, Qamar Zaza, Adam Benbachir, Oumaima Skalante, Soufiane Benaazza, Mohamed Allaoui, Yassine Ben Lahlou, Elmostafa Benaissa, Mariama Chadli

    Extrapulmonary tuberculosis often presents as lymphadenitis. In the head and neck area, tuberculous involvement of the parotid gland is rare and challenging to diagnose due to non-specific symptoms, which can be confused with a tumour. Tuberculous conjunctivitis, although uncommon, should be considered in cases of chronic, treatment-resistant conjunctivitis. The association of primary parotid and conjunctival tuberculosis is exceptional. They are difficult to diagnose due to the non-specificity of their clinical, biological and radiological signs. We report the case of a 24-year-old immunocompetent patient with no history of tuberculosis, who presented with intermittent swelling of the left parotid gland, accompanied by unilateral redness of the eye, which appeared 2 months later, in a context of fever and night sweats. The patient also reported a foreign body sensation in his eye, mild tearing and photophobia. Clinical examination revealed painful, warm swelling of the left parotid gland, as well as localized granulomatous conjunctivitis. Cervico-parotid CT and MRI revealed two well-limited, oval, left parotid formations with a slightly thickened and enhanced wall after injection of gadolinium, suggestive a priori of abscessed collections. The diagnosis of primary parotid and conjunctival tuberculosis was made on the basis of histological examination of the biopsies, as well as direct examination, culture and GeneXpert. The patient progressed well on anti-bacillary treatment. Our work underlines the great importance of GeneXpert, which is a rapid and highly sensitive technique, effective in the diagnosis of extrapulmonary tuberculosis.